GlassScriptPhysician profile
Tiffany G Son
NPI 1114373388
$47,018.82
in general payments reported to CMS, 2019-2025
16 companies · $18K in 2025
The $18K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.95 · 2022: $4,830 · 2023: $6,605 · 2024: $17K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $28K · Food and Beverage: $7,661 · Travel and Lodging: $4,861 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,575 · Gift: $49.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $28,009.64 |
| Food and Beverage | $7,661.24 |
| Travel and Lodging | $4,861.03 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,575.00 |
| Gift | $49.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $40,651.22 | 2022-2025 | Da Vinci Surgical System |
| Davol INC. | $2,845.26 | 2023-2025 | Phasix Mesh |
| Medtronic, INC. | $1,408.40 | 2022-2025 | Signia, Progrip |
| Phathom Pharmaceuticals, INC. | $1,075.00 | 2024 | Voquezna |
| Novo Nordisk INC | $299.33 | 2022-2025 | Wegovy |
| Trimed, INC. | $141.61 | 2022 | |
| Ethicon US, LLC | $133.64 | 2024 | Stratafix, Echelon Flex, Echelon Endopath |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2024 | Tezspire |
| Hologic Sales and Service, LLC | $111.89 | 2025 | Myosure Tissue Removal Device, Acessa Provu System |
| Takeda Pharmaceuticals U.S.A., INC. | $94.36 | 2023 | Gattex |
| Baxter Healthcare | $31.95 | 2019 | |
| Lilly USA, LLC | $25.02 | 2023 | Taltz |
| Tela Bio, INC. | $24.27 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Boston Scientific Corporation | $19.26 | 2025 | Spyglass Discover |
| Advanced Oxygen Therapy INC. | $16.86 | 2023 | Topical Oxygen Chamber For Extremities |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $15.75 | 2023 | Libtayo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Son listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.